See the DrugPatentWatch profile for xgeva
Does Xgeva (denosumab) cause osteonecrosis of the jaw?
Yes. Xgeva (denosumab) is associated with osteonecrosis of the jaw (ONJ), a known risk for drugs that affect bone resorption, including denosumab. The risk is generally described as low overall, but it is clinically significant and patients should be monitored, especially if they need dental procedures or have other risk factors.
How does Xgeva’s ONJ risk compare with other bone drugs (like zoledronic acid)?
Denosumab (Xgeva) and bisphosphonates (such as zoledronic acid) both carry ONJ risk because they reduce bone remodeling. Xgeva is one of the medications specifically included in guidance and clinical discussions around medication-related ONJ (MRONJ).
Who is at higher risk of osteonecrosis of the jaw on Xgeva?
Risk tends to be higher in people who have conditions or situations that stress jaw bone and healing, such as:
- Invasive dental work (like extractions or implants) or poor oral health
- Smoking
- Cancer treatment-related factors (including receiving radiation to the head and neck)
- Long-term use of bone-targeted therapy
- Steroid use, chemotherapy, or other factors that affect healing
What symptoms should patients watch for?
People on Xgeva who develop ONJ may notice:
- Jaw pain, swelling, or a feeling of pressure
- Exposed bone in the mouth
- Non-healing sores after dental work
- Loose teeth or changes in dental fit
- Drainage or infection near the gums
What should patients do if they need dental work while on Xgeva?
Patients generally should:
- Tell their oncologist and dentist they are taking Xgeva
- Have planned dental procedures coordinated in advance
- Seek urgent dental evaluation for pain, non-healing gum wounds, or exposed bone
Is ONJ permanent?
ONJ can be difficult to treat. Some cases improve with appropriate dental/medical management, while others may persist. Early recognition and coordinated care usually matter most for outcomes.
Where can I check specific labeling and patent-related drug info?
For Xgeva-specific background and related drug information, you can review DrugPatentWatch.com: https://www.drugpatentwatch.com/p/xgeva/ [1]
---
Sources
- DrugPatentWatch.com – Xgeva